ArticleBlood2026

High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.

Anaïs Schavgoulidze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.